Introduction
Healthcare associated infections which mainly includes hospital or community acquired infections are persisting factor in each and every healthcare system. Increase in occurrence of hospital acquired infections and advancements in sterilization and disinfection technologies are making the infection prevention and control market promising. For reduction of hospital acquired infections, infection prevention control organizations are applying epidemiologic and scientific principles and statistic analysis. Along with this, from the past decade there is a progressive refinement in sterilizing technologies from manually operated equipment to modern microprocessor controlled automatic machines. Plasma sterilization and use of electrostatics for surface disinfection are emerging and promising technologies in sterilizers and disinfectant market. Infection control products are used in a wide variety of applications like in healthcare settings, food and beverage industries, drug discovery, dental clinics and cosmetics. In recent times there is an advancement in sterilizing surgical tools in hospital settings by using robotic surgical tool sterilization process and thus promoting sufficient process of sterilization.
The global infection control market is expected to grow at a single digit high CAGR% to reach ,582 million by 2022. Infection control market is mainly classified into products and end-users.
The infection control market by products is segmented into disinfection and sterilization. The disinfection market is further sub-segmented into the disinfectors which include washers, flushers and UV rays disinfectors, the endoscope reprocessors, the disinfectants and personal protective equipments (PPE). The disinfectants are divided by product type and EPA classification. Hand, skin, instrument and surface disinfectants are categorized under product type while low-level, intermediate level and high level disinfectants are divided under EPA classification segment. The personal protective equipment includes gloves and foot covers, surgical masks and respirators, surgical drapes and gowns, disinfectant wipes and others (protective eye-wears and sterilization wraps).
The infection control by sterilization is classified by methods and services. The sterilization market by method involves the heat sterilization which further includes wet/moist heat sterilization and dry sterilization, the low temperature sterilization including ethylene oxide sterilization (ETO), vaporized hydrogen peroxide (VHP), hydrogen peroxide gas plasma, peracetic acid, ozone gas, formaldehyde sterilization and chlorine dioxide, the filtration sterilization and the radiation sterilization contains ionizing and non-ionizing radiation. However the sterilization market by services is segmented into in-house sterilization services and contract sterilization services. Both the in-house and contract sterilization provides ethylene oxide sterilization, gamma sterilization, e-beam sterilization and other sterilization services.
The end-users of infection control market are pharmaceuticals, biotechnology, hospitals, research laboratories and others. The hospital end-user segment consists of dental clinics, nursing centres and ambulatory services, while the other end-users of this market are cosmetics, food and beverage and veterinary.
Among the products, disinfection segment holds the largest share and sterilization is the fastest growing segment from 2015 to 2022. By end-users, hospital is the largest segment and is the fastest segment from 2015 to 2022. Geographical wise, North America is the largest market, with a share of 39.5% followed by Europe, Asia and Rest of the World. The Asia region is the fastest growing region from 2015 to 2022 suggesting an array of opportunities for growth and likely to be getting into the eyes of new investors in the Infection prevention and control market. Growth in the Asia-Pacific market is attributed to implementation of practical evidence based, low cost and simple preventive strategies, obtaining fund research projects via ICMR, DBT and state agencies and training infection control professionals and nurses.
The Infection Control market is expected to grow at a single digit high CAGR during 2015 to 2022. The factors driving the growth of this market are increase in aging population, rising occurrence of hospital acquired infections, increase in number of surgeries performed, proper maintenance of hygiene among hospital staff and increasing awareness among people. While rise in trend for e-beam radiation sterilization through service sterilization industry and growth of single use technology products in developing countries are some of the opportunities that are propelling the growth of the market. However stringent regulations and economic downturn and saturation are hampering the growth of the market.
The Infection Control global market is a highly fragmented market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares. Some of the key players of the infection control market are 3M Company (U.S.), Advanced Sterilization Products (U.S.), Ansell Limited (Australia), Belimed (Switzerland), Cantel Medical (U.S.), Getinge Group (Sweden), Halyard Health (U.S.), Hartmann Group (Germany), Sterigenics International, Inc., (U.S.) and Steris Corporation (U.S.).
The report provides an in depth market analysis of the above mentioned segments across the following regions:
• North America
• Europe
• Asia-Pacific
• Rest of the World (RoW)
Table of Contents
for Infection Control (Disinfection & Sterilization) Global Market - Forecast to 2022
1 EXECUTIVE SUMMARY 31
2 INTRODUCTION 38
2.1 KEY TAKE AWAYS 38
2.2 REPORT DESCRIPTION 38
2.3 MARKETS COVERED 41
2.4 STAKEHOLDERS 43
2.5 RESEARCH METHODOLOGY 44
2.5.1 MARKET SIZE ESTIMATION 45
2.5.2 MARKET CRACKDOWN AND DATA TRIANGULATION 48
2.5.3 SECONDARY SOURCES 49
2.5.4 KEY DATA POINTS FROM SECONDARY SOURCES 50
2.5.5 PRIMARY SOURCES 51
2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES 51
2.5.7 ASSUMPTIONS 51
3 MARKET ANALYSIS 53
3.1 INTRODUCTION 53
3.2 MARKET SEGMENTATION 54
3.3 FACTORS INFLUENCING MARKET 56
3.3.1 DRIVERS AND OPPORTUNITIES 57
3.3.1.1 Increase in aging population 57
3.3.1.2 Increase in number of surgeries performed 57
3.3.1.3 Rising occurrence of hospital acquired infections 58
3.3.1.4 Increasing awareness among people 59
3.3.1.5 Proper maintenance of hygiene among hospital staff 60
3.3.1.6 Rise in trend for e-beam radiation sterilization through service
sterilization industry 61
3.3.1.7 Single use technology (medical non-woven) products, an opportunity
especially in developing countries 61
3.3.2 RESTRAINTS & THREATS 62
3.3.2.1 Economic downturn and saturation of market in developed countries 62
3.3.2.2 High cost of robotic technologies 63
3.3.2.3 Stringent regulations 64
3.3.2.4 Availability of alternative technologies 65
3.3.3 CHALLENGES 66
3.3.3.1 Sterilization and disinfection of advanced medical instruments 66
3.4 PORTER’S FIVE FORCE ANALYSIS 67
3.4.1 THREAT OF NEW ENTRANTS 68
3.4.2 THREAT OF SUBSTITTES 68
3.4.3 BARGAINING POWER OF SUPPLIERS 69
3.4.4 BARGAINING POWER OF BUYERS 69
3.4.5 RIVALRY AMONG EXISTING COMPETITORS 69
3.5 REGULATORY GUIDELINES 70
3.5.1 UNITED STATES 70
3.5.2 EUROPE 72
3.5.3 CHINA 73
3.5.4 AUSTRALIA 75
3.6 PATENT TRENDS 76
3.7 INFECTIONS 78
3.7.1 MICROBIAL INFECTIONS 78
3.7.1.1 Bacterial infections 78
3.7.1.1.1 Mycobacterium tuberculosis 79
3.7.1.1.2 Clostridium difficile 79
3.7.1.1.3 Escherichia coli 80
3.7.1.1.4 Helicobacter pylori 81
3.7.1.1.5 Salmonella 81
3.7.1.1.6 Others 82
3.7.1.2 Viral infections 83
3.7.1.2.1 Ebola 83
3.7.1.2.2 Human immunodeficiency virus (HIV) 84
3.7.1.2.3 Herpes simplex virus 86
3.7.1.2.4 Yellow fever 86
3.7.1.2.5 Dengue fever 87
3.7.1.2.6 Others 88
3.7.1.3 Fungal infections 88
3.7.1.3.1 Cryptococcus gatti 89
3.7.1.3.2 Aspergillus 89
3.7.1.3.3 Pneumocystis jiroveci 89
3.7.1.3.4 Fungal keratitis 90
3.7.1.3.5 Dermatophytosis 90
3.7.1.3.6 Others 91
3.7.2 HEALTHCARE ASSOCIATED INFCETIONS (HCAI) 92
3.7.2.1 Hospital acquired infections (HAI) 93
3.7.2.1.1 Central-line associated bloodstream infection (CLABSI) 94
3.7.2.1.2 Catheter associated urinary tract infection (CAUTI) 95
3.7.2.1.3 Surgical site infection (SSI) 96
3.7.2.1.4 Ventilator-associated pneumonia infection (VAPI) 97
3.7.2.2 Community acquired infection 97
3.7.2.2.1 Methicillin-resistant staphylococcus aureus (MRSA) infection 98
3.7.2.2.2 Community acquired pneumonia 99
3.8 OTHER STERILIZATION AND DISINFECTION TECHNIQUES 100
3.8.1 SUPERCRITICAL CARBON-DIOXIDE TECHNOLOGY (SF-CO2) 100
3.8.2 NITROGEN DIOXIDES (NO2) 101
3.8.3 PULSED ELECTRICAL FIELD (PEF) STERILIZATION 102
3.8.4 MICROWAVE ENERGY STERILIZATION 102
3.8.5 PHOTOCATALYSIS 104
3.8.6 ULTRASONIC TECHNOLOGY 105
3.9 MARKET SHARE ANALYSIS 107
4 INFECTION CONTROL GLOBAL MARKET, BY PRODUCTS 110
4.1 INTRODUCTION 110
4.2 DISINFECTION 112
4.2.1 INTRODUCTION 112
4.2.2 DISINFECTORS 116
4.2.2.1 Washer disinfectors 120
4.2.2.2 Flushers disinfectors 123
4.2.2.3 UV rays disinfectors 125
4.2.3 ENDOSCOPE REPROCESSORS 128
4.2.4 DISINFECTANTS 130
4.2.4.1 By product type 133
4.2.4.1.1 Hand 136
4.2.4.1.2 Skin 139
4.2.4.1.3 Surface 140
4.2.4.1.4 Instrument 143
4.2.4.2 By environmental protection agency (EPA) classification 145
4.2.4.2.1 Low-level disinfectants (LLD) 147
4.2.4.2.2 Intermediate-level disinfectants (ILD) 148
4.2.4.2.3 High-level disinfectants (HLD) 150
4.2.5 PERSONAL PROTECTIVE EQUIPMENTS 151
4.2.5.1 Gloves and foot covers 154
4.2.5.2 Surgical masks and respirators 158
4.2.5.3 Surgical drapes and gowns 161
4.2.5.4 Disinfectant wipes 163
4.2.5.5 Others 165
4.2.5.5.1 Protective eye-wears 165
4.2.5.5.2 Sterilization wraps 167
4.3 STERILIZATION 169
4.3.1 INTRODUCTION 169
4.3.2 STERILIZATION, BY METHOD 172
4.3.2.1 Heat sterilization 175
4.3.2.1.1 Wet/Moist heat sterilization 178
4.3.2.1.1.1 Vertical autoclave 181
4.3.2.1.1.2 Horizontal autoclave 183
4.3.2.1.1.3 Portable autoclave 184
4.3.2.1.2 Dry heat sterilization 185
4.3.2.1.3 Low temperature sterilization 188
4.3.2.1.3.1 Ethylene oxide sterilization 191
4.3.2.1.3.2 Hydrogen peroxide 194
4.3.2.1.3.3 Vapor hydrogen peroxide sterilization 195
4.3.2.1.3.4 Peracetic acid 197
4.3.2.1.3.5 Ozone gas 199
4.3.2.1.3.6 Formaldehyde sterilization 201
4.3.2.1.3.7 Chlorine dioxide sterilization 203
4.3.2.1.4 Filtration sterilization 205
4.3.2.1.5 Radiation sterilization 207
4.3.2.1.5.1 Ionizing radiation 209
4.3.2.1.5.2 Non-ionizing radiation 211
4.3.3 STERILIZATION BY SERVICES 212
4.3.3.1 In-house sterilization services 215
4.3.3.1.1 Ethylene oxide sterilization 219
4.3.3.1.2 E-beam sterilization 220
4.3.3.1.3 Gamma sterilization 222
4.3.3.1.4 Other in-house sterilization services 224
4.3.3.2 Contract sterilization services 226
4.3.3.2.1 Ethylene oxide sterilization 230
4.3.3.2.2 E-beam sterilization 231
4.3.3.2.3 Gamma sterilization 233
4.3.3.2.4 Other contract sterilization services 234
5 INFECTION CONTROL GLOBAL MARKET, BY END-USERS 236
5.1 INTRODUCTION 236
5.2 PHARMACEUTICALS 238
5.3 BIOTECHNOLOGY 240
5.4 HOSPITALS 242
5.4.1 DENTAL CLINICS 245
5.4.2 NURSING CENTERS 246
5.4.3 AMBULATORY SURGICAL CENTRES 248
5.5 RESEARCH LABORATORIES 249
5.6 OTHERS 251
5.6.1 COSMETICS 251
5.6.2 FOOD AND BEVERAGE 252
5.6.3 VETERINARY 253
6 REGIONAL ANALYSIS 255
6.1 INTRODUCTION 255
6.2 NORTH AMERICA 257
6.2.1 UNITED STATES 258
6.2.2 CANADA 259
6.3 EUROPE 279
6.4 ASIA-PACIFIC 301
6.4.1 INDIA 302
6.4.2 CHINA 303
6.4.3 JAPAN 304
6.5 REST OF THE WORLD 325
6.5.1 SOUTH AFRICA 325
6.5.2 MIDDLE EAST 326
7 COMPETITIVE LANDSCAPE 347
7.1 INTRODUCTION 347
7.2 NEW PRODUCT LAUNCHES 348
7.3 AGREEMENTS, PARTNERSHIP, COLLABORATION & JOINT VENTURES 351
7.4 APPROVALS 353
7.5 EXPANSIONS 354
7.6 MERGERS & ACQUISITIONS 356
8 MAJOR COMPANIES 362
8.1 3M COMPANY 362
8.1.1 OVERVIEW 362
8.1.2 FINANCIALS 363
8.1.3 PRODUCT PORTFOLIO 366
8.1.4 KEY DEVELOPMENTS 367
8.1.5 BUSINESS STRATEGY 367
8.1.6 SWOT ANALYSIS 368
8.2 ANSELL LIMITED 369
8.2.1 OVERVIEW 369
8.2.2 FINANCIALS 370
8.2.3 PRODUCT PORTFOLIO 372
8.2.4 KEY DEVELOPMENTS 377
8.2.5 BUSINESS STRATEGY 378
8.2.6 SWOT ANALYSIS 379
8.3 CANTEL MEDICAL 380
8.3.1 OVERVIEW 380
8.3.2 FINANCIALS 381
8.3.3 PRODUCT PORTFOLIO 383
8.3.4 KEY DEVELOPMENTS 385
8.3.5 BUSINESS STRATEGY 388
8.3.6 SWOT ANALYSIS 389
8.4 GETINGE GROUP 390
8.4.1 OVERVIEW 390
8.4.2 FINANCIALS 391
8.4.3 PRODUCT PORTFOLIO 393
8.4.4 KEY DEVELOPMENTS 396
8.4.5 BUSINESS STRATEGY 397
8.4.6 SWOT ANALYSIS 398
8.5 HALYARD HEALTH INC. 399
8.5.1 OVERVIEW 399
8.5.2 FINANCIALS 400
8.5.3 PRODUCT PORTFOLIO 403
8.5.4 KEY DEVELOPMENTS 410
8.5.5 BUSINESS STRATEGY 412
8.5.6 SWOT ANALYSIS 413
8.6 HARTMANN 414
8.6.1 OVERVIEW 414
8.6.2 FINANCIALS 415
8.6.3 PRODUCT PORTFOLIO 417
8.6.4 KEY DEVELOPMENTS 418
8.6.5 BUSINESS STRATEGY 418
8.6.6 SWOT ANALYSIS 419
8.7 JOHNSON & JOHNSON (ADVANCED STERILIZATION PRODUCTS) 420
8.7.1 OVERVIEW 420
8.7.2 FINANCIALS 421
8.7.3 PRODUCT PORTFOLIO 423
8.7.4 KEY DEVELOPMENTS 424
8.7.5 BUSINESS STRATEGY 424
8.7.6 SWOT ANALYSIS 425
8.8 METALL ZUG (BELIMED) 426
8.8.1 OVERVIEW 426
8.8.2 FINANCIALS 427
8.8.3 PRODUCT PORTFOLIO 429
8.8.4 KEY DEVELOPMENTS 431
8.8.5 BUSINESS STRATEGY 431
8.8.6 SWOT ANALYSIS 432
8.9 STERIGENICS INTERNATIONAL, INC. 433
8.9.1 OVERVIEW 433
8.9.2 FINANCIALS 433
8.9.3 PRODUCT PORTFOLIO 434
8.9.4 KEY DEVELOPMENTS 434
8.9.5 BUSINESS STRATEGY 437
8.9.6 SWOT ANALYSIS 438
8.10 STERIS CORPORATION 439
8.10.1 OVERVIEW 439
8.10.2 FINANCIALS 440
8.10.3 PRODUCT PORTFOLIO 442
8.10.4 KEY DEVELOPMENTS 450
8.10.5 BUSINESS STRATEGY 452
8.10.6 SWOT ANALYSIS 453
List Of Tables
in Infection Control Global Market - Forecast to 2022
LIST OF TABLES
TABLE 1 INFECTION CONTROL GLOBAL MARKET REVENUE, BY REGION,
(2014-2022) ($MN) 35
TABLE 2 INFECTION CONTROL GLOBAL MARKET REVENUE, BY PRODUCTS,
(2014-2022) ($MN) 36
TABLE 3 INFECTION CONTROL GLOBAL MARKET REVENUE, BY ENDUSERS,
(2014-2022) ($MN) 37
TABLE 4 INFECTION CONTROL GLOBAL MARKET REVENUE, BY PRODUCTS,
(2014-2022) ($MN) 112
TABLE 5 INFECTION CONTROL DISINFECTION GLOBAL MARKET REVENUE,
BY REGION, (2014-2022) ($MN) 115
TABLE 6 INFECTION CONTROL DISINFECTION GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 116
TABLE 7 INFECTION CONTROL DISINFECTORS GLOBAL MARKET REVENUE,
BY REGION, (2014-2022) ($MN) 119
TABLE 8 INFECTION CONTROL DISINFECTORS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 120
TABLE 9 INFECTION CONTROL WASHER DISINFECTORS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 123
TABLE 10 INFECTION CONTROL FLUSHER DISINFECTORS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 125
TABLE 11 INFECTION CONTROL UV RAYS DISINFECTORS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 127
TABLE 12 INFECTION CONTROL ENDOSCOPE REPROCESSORS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 130
TABLE 13 INFECTION CONTROL DISINFECTANTS GLOBAL MARKET REVENUE,
BY REGION, (2014-2022) ($MN) 132
TABLE 14 INFECTION CONTROL DISINFECTANTS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 133
TABLE 15 INFECTION CONTROL DISINFECTANT PRODUCTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 135
TABLE 16 INFECTION CONTROL DISINFECTANT PRODUCTS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 136
TABLE 17 INFECTION CONTROL HAND DISINFECTANTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 138
TABLE 18 INFECTION CONTROL SKIN DISINFECTANT GLOBAL MARKET REVENUE,
BY REGION, (2014-2022) ($MN) 140
TABLE 19 INFECTION CONTROL SURFACE DISINFECTANT GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 142
TABLE 20 INFECTION CONTROL INSTRUMENT DISINFECTANT GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 144
TABLE 21 INFECTION CONTROL DISINFECTANTS EPA CLASSIFICATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 146
TABLE 22 INFECTION CONTROL DISINFECTANTS EPA CLASSIFICATION GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 147
TABLE 23 INFECTION CONTROL LOW-LEVEL DISINFECTANT GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 148
TABLE 24 INFECTION CONTROL INTERMEDIATE-LEVEL DISINFECTANT GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 149
TABLE 25 INFECTION CONTROL HIGH-LEVEL DISINFECTANT GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 151
TABLE 26 INFECTION CONTROL PERSONAL PROTECTIVE EQUIPMENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 153
TABLE 27 INFECTION CONTROL PERSONAL PROTECTIVE EQUIPMENTS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 154
TABLE 28 INFECTION CONTROL GLOVES AND FOOT COVERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 158
TABLE 29 INFECTION CONTROL SURGICAL MASKS AND RESPIRATORS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 161
TABLE 30 INFECTION CONTROL SURICAL DRAPES AND GOWNS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 163
TABLE 31 INFECTION CONTROL DISINFECTANT WIPES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 165
TABLE 32 INFECTION CONTROL OTHER PERSONAL PROTECTIVE EQUIPMENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 169
TABLE 33 INFECTION CONTROL STERILIZATION PRODUCTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 171
TABLE 34 INFECTION CONTROL STERILIZATION PRODUCTS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 172
TABLE 35 INFECTION CONTROL STERILIZATION METHODS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 174
TABLE 36 INFECTION CONTROL STERILIZATION METHODS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 175
TABLE 37 INFECTION CONTROL HEAT STERILIZATION GLOBAL MARKET REVENUE,
BY REGION, (2014-2022) ($MN) 177
TABLE 38 INFECTION CONTROL HEAT STERILIZATION GLOBAL MARKET REVENUE,
BY TYPE, (2014-2022) ($MN) 178
TABLE 39 INFECTION CONTROL WET/MOIST HEAT STERILIZATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 180
TABLE 40 INFECTION CONTROL WET/MOIST HEAT STERILIZATION GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 181
TABLE 41 INFECTION CONTROL VERTICAL AUTOCLAVE GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 182
TABLE 42 INFECTION CONTROL HORIZONTAL AUTOCLAVE GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 184
TABLE 43 INFECTION CONTROL PORTABLE AUTOCLAVE GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 185
TABLE 44 INFECTION CONTROL GLOBAL MARKET REVENUE, BY PRODUCTS,
(2014-2022) ($MN) 187
TABLE 45 INFECTION CONTROL LOW TEMPERATURE STERILIZATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 190
TABLE 46 INFECTION CONTROL LOW TEMPERATURE STERILIZATION GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 191
TABLE 47 INFECTION CONTROL ETHYLENE OXIDE LOW TEMPERATURE STERILIZATION GLOBAL MARKET REVENUE, BY REGION,
(2014-2022) ($MN) 193
TABLE 48 INFECTION CONTROL HYDROGEN PEROXIDE LOW TEMPERATURE STERILIZATIONGLOBAL MARKET REVENUE, BY REGION,
(2014-2022) ($MN) 195
TABLE 49 INFECTION CONTROL VAPOR HYDROGEN PEROXIDE LOW TEMPERATURE STERILIZATION GLOBAL MARKET REVENUE, BY REGION,
(2014-2022) ($MN) 197
TABLE 50 INFECTION CONTROL PERACETIC ACID LOW TEMPERATURE STERILIZATION GLOBAL MARKET REVENUE, BY REGION,
(2014-2022) ($MN) 199
TABLE 51 INFECTION CONTROL OZONE GAS LOW TEMPERATURE STERILIZATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 201
TABLE 52 INFECTION CONTROL FORMALDEHYDE LOW TEMPERATURE STERILZATION GLOBAL MARKET REVENUE, BY REGION,
(2014-2022) ($MN) 203
TABLE 53 INFECTION CONTROL CHLORINE DIOXIDE LOW TEMPERATURE STERILIZATION GLOBAL MARKET REVENUE, BY PRODUCTS,
(2014-2022) ($MN) 204
TABLE 54 INFECTION CONTROL FILTRATION STERILIZATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 206
TABLE 55 INFECTION CONTROL RADIATION STERILIZATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 208
TABLE 56 INFECTION CONTROL RADIATION STERILIZATION GLOBAL MARKET REVENUE, BY TYPES, (2014-2022) ($MN) 209
TABLE 57 INFECTION CONTROL IONIZING RADIATION STERILIZATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 211
TABLE 58 INFECTION CONTROL NON-IONIZING RADIATION STERILIZATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 212
TABLE 59 INFECTION CONTROL STERILIZATION SERVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 214
TABLE 60 INFECTION CONTROL STERILIZATION SERVICES GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 215
TABLE 61 INFECTION CONTROL IN-HOUSE STERILIZATION SERVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 218
TABLE 62 INFECTION CONTROL IN-HOUSE STERILIZATION SERVICES GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 219
TABLE 63 INFECTION CONTROL ETHYLENE OXIDE IN-HOUSE STERILIZATION SERVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 220
TABLE 64 INFECTION CONTROL E-BEAM IN-HOUSE STERILIZATION SERVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 222
TABLE 65 INFECTION CONTROL GAMMA IN-HOUSE STERILIZATION SERVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 224
TABLE 66 INFECTION CONTROL OTHER IN-HOUSE STERILIZATION SERVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 226
TABLE 67 INFECTION CONTROL CONTRACT STERILIZATION SERVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 229
TABLE 68 INFECTION CONTROL CONTRACT STERILIZATION SERVICES GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 230
TABLE 69 INFECTION CONTROL ETHYLENE OXIDE CONTRACT STERILIZATION SERVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 231
TABLE 70 INFECTION CONTROL E-BEAM CONTRACT STERILIZATION SERVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 233
TABLE 71 INFECTION CONTROL GAMMA CONTRACT STERILIZATION SERVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 234
TABLE 72 INFECTION CONTROL OTHER CONTRACT STERILIZATION SERVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 235
TABLE 73 INFECTION CONTROL GLOBAL MARKET REVENUE, BY END-USERS,
(2014-2022) ($MN) 238
TABLE 74 INFECTION CONTROL PHARMACEUTICAL END-USERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 240
TABLE 75 INFECTION CONTROL BIOTECHNOLOGY END-USERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 242
TABLE 76 INFECTION CONTROL HOSPITAL END-USERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 244
TABLE 77 INFECTION CONTROL HOSPITAL END-USERS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 245
TABLE 78 INFECTION CONTROL DENTAL CLINIC END-USERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 246
TABLE 79 INFECTION CONTROL NURSING CENTRE END-USERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 247
TABLE 80 INFECTION CONTROL AMBULATORY SURGICAL CENTRE END-USERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 249
TABLE 81 INFECTION CONTROL RESEARCH LABORATORIES END-USERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 250
TABLE 82 INFECTION CONTROL OTHER END-USERS GLOBAL MARKET REVENUE,
BY REGION, (2014-2022) ($MN) 254
TABLE 83 INFECTION CONTROL GLOBAL MARKET REVENUE, BY REGION,
(2014-2022) ($MN) 257
TABLE 84 NORTH AMERICAN INFECTION CONTROL MARKET REVENUE,
BY PRODUCTS, (2014-2022) ($MN) 262
TABLE 85 NORTH AMERICAN INFECTION CONTROL DISINFECTION PRODUCTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 263
TABLE 86 NORTH AMERICAN INFECTION CONTROL DISINFECTORS MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 264
TABLE 87 NORTH AMERICAN INFECTION CONTROL DISINFECTANTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 265
TABLE 88 NORTH AMERICAN INFECTION CONTROL DISINFECTANTS MARKET REVENUE, BY PRODUCT TYPE, (2014-2022) ($MN) 266
TABLE 89 NORTH AMERICAN INFECTION CONTROL DISINFECTANTS MARKET REVENUE, BY EPA CLASSIFICATION, (2014-2022) ($MN) 267
TABLE 90 NORTH AMERICAN INFECTION CONTROL PERSONAL PROTECTIVE EQUIPMENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 268
TABLE 91 NORTH AMERICAN INFECTION CONTROL STERILIZATION PRODUCTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 269
TABLE 92 NORTH AMERICAN INFECTION CONTROL STERILIZATION METHODS MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 270
TABLE 93 NORTH AMERICAN INFECTION CONTROL HEAT STERILIZATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 271
TABLE 94 NORTH AMERICAN INFECTION CONTROL WET/MOIST HEAT STERILIZATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 272
TABLE 95 NORTH AMERICAN INFECTION CONTROL LOW TEMPERATURE STERILIZATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 273
TABLE 96 NORTH AMERICAN INFECTION CONTROL RADIATION STERILIZATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 274
TABLE 97 NORTH AMERICAN INFECTION CONTROL STERILIZATION SERVICES MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 275
TABLE 98 NORTH AMERICAN INFECTION CONTROL IN-HOUSE STERILIZATION SERVICES MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 276
TABLE 99 NORTH AMERICAN INFECTION CONTROL CONTRACT STERILIZATION SERVICES MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 277
TABLE 100 NORTH AMERICAN INFECTION CONTROL MARKET REVENUE,
BY END-USERS, (2014-2022) ($MN) 278
TABLE 101 NORTH AMERICAN INFECTION CONTROL HOSPITAL END-USERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 279
TABLE 102 EUROPEAN INFECTION CONTROL MARKET REVENUE, BY PRODUCTS,
(2014-2022) ($MN) 284
TABLE 103 EUROPEAN INFECTION CONTROL DISINFECTION PRODUCTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 285
TABLE 104 EUROPEAN INFECTION CONTROL DISINFECTORS MARKET REVENUE,
BY TYPE, (2014-2022) ($MN) 286
TABLE 105 EUROPEAN INFECTION CONTROL DISINFECTANTS MARKET REVENUE,
BY TYPE, (2014-2022) ($MN) 287
TABLE 106 EUROPEAN INFECTION CONTROL DISINFECTANTS MARKET REVENUE,
BY PRODUCT TYPE, (2014-2022) ($MN) 288
TABLE 107 EUROPEAN INFECTION CONTROL DISINFECTANTS MARKET REVENUE,
BY EPA CLASSIFICATION, (2014-2022) ($MN) 289
TABLE 108 EUROPEAN INFECTION CONTROL PERSONAL PROTECTIVE EQUIPMENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 290
TABLE 109 EUROPEAN INFECTION CONTROL STERILIZATION PRODUCTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 291
TABLE 110 EUROPEAN INFECTION CONTROL STERILIZATION METHODS MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 292
TABLE 111 EUROPEAN INFECTION CONTROL HEAT STERILIZATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 293
TABLE 112 EUROPEAN INFECTION CONTROL WET/MOIST STERILIZATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 294
TABLE 113 EUROPEAN INFECTION CONTROL LOW TEMPERATURE STERILIZATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 295
TABLE 114 EUROPEAN INFECTION CONTROL RADIATION STERILIZATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 296
TABLE 115 EUROPEAN INFECTION CONTROL STERILIZATION SERVICES MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 297
TABLE 116 EUROPEAN INFECTION CONTROL IN-HOUSE STERILIZATION SERVICES MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 298
TABLE 117 EUROPEAN INFECTION CONTROL CONTRACT STERILIZATION SERVICES MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 299
TABLE 118 EUROPEAN INFECTION CONTROL MARKET REVENUE, BY END-USERS, (2014-2022) ($MN) 300
TABLE 119 EUROPEAN INFECTION CONTROL HOSPITAL END-USERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 301
TABLE 120 ASIA-PACIFIC INFECTION CONTROL MARKET REVENUE, BY PRODUCTS, (2014-2022) ($MN) 307
TABLE 121 ASIA-PACIFIC INFECTION CONTROL DISINFECTION PRODUCTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 308
TABLE 122 ASIA-PACIFIC INFECTION CONTROL DISINFECTORS MARKET REVENUE,
BY TYPE, (2014-2022) ($MN) 309
TABLE 123 ASIA-PACIFIC INFECTION CONTROL DISINFECTANTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 310
TABLE 124 ASIA-PACIFIC INFECTION CONTROL DISINFECTANTS MARKET REVENUE, BY PRODUCT TYPE, (2014-2022) ($MN) 311
TABLE 125 ASIA-PACIFIC INFECTION CONTROL DISINFECTANTS MARKET REVENUE, BY EPA CLASSIFICATION, (2014-2022) ($MN) 312
TABLE 126 ASIA-PACIFIC INFECTION CONTROL PERSONAL PROTECTIVE EQUIPMENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 313
TABLE 127 ASIA-PACIFIC INFECTION CONTROL STERILIZATION PRODUCTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 314
TABLE 128 ASIA-PACIFIC INFECTION CONTROL STERILIZATION METHODS MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 315
TABLE 129 ASIA-PACIFIC INFECTION CONTROL HEAT STERILIZATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 316
TABLE 130 ASIA-PACIFIC INFECTION CONTROL WET/MOIST STERILIZATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 317
TABLE 131 ASIA-PACIFIC INFECTION CONTROL LOW TEMPERATURE STERILIZATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 318
TABLE 132 ASIA-PACIFIC INFECTION CONTROL RADIATION STERILIZATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 319
TABLE 133 ASIA-PACIFIC INFECTION CONTROL STERILIZATION SERVICES MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 320
TABLE 134 ASIA-PACIFIC INFECTION CONTROL IN-HOUSE STERILIZATION SERVICES MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 321
TABLE 135 ASIA-PACIFIC INFECTION CONTROL CONTRACT STERILIZATION SERVICES MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 322
TABLE 136 ASIA-PACIFIC INFECTION CONTROL MARKET REVENUE,
BY END-USERS, (2014-2022) ($MN) 323
TABLE 137 ASIA-PACIFIC INFECTION CONTROL HOSPITAL END-USERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 324
TABLE 138 REST OF THE WORLD INFECTION CONTROL MARKET REVENUE,
BY PRODUCTS, (2014-2022) ($MN) 329
TABLE 139 REST OF THE WORLD INFECTION CONTROL DISINFECTION PRODUCTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 330
TABLE 140 REST OF THE WORLD INFECTION CONTROL DISINFECTORS MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 331
TABLE 141 REST OF THE WORLD INFECTION CONTROL DISINFECTANTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 332
TABLE 142 REST OF THE WORLD INFECTION CONTROL DISINFECTANTS MARKET REVENUE, BY PRODUCT TYPE, (2014-2022) ($MN) 333
TABLE 143 REST OF THE WORLD INFECTION CONTROL DISINFECTANTS MARKET REVENUE, BY EPA CLASSIFICATION, (2014-2022) ($MN) 334
TABLE 144 REST OF THE WORLD INFECTION CONTROL PERSONAL PROTECTIVE EQUIPMENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 335
TABLE 145 REST OF THE WORLD INFECTION CONTROL STERILIZATION PRODUCTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 336
TABLE 146 REST OF THE WORLD INFECTION CONTROL STERILIZATION METHODS MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 337
TABLE 147 REST OF THE WORLD INFECTION CONTROL HEAT STERILIZATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 338
TABLE 148 REST OF THE WORLD INFECTION CONTROL WET/MOIST STERILIZATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 339
TABLE 149 REST OF THE WORLD INFECTION CONTROL LOW TEMPERATURE STERILIZATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 340
TABLE 150 REST OF THE WORLD INFECTION CONTROL RADIATION STERILIZATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 341
TABLE 151 REST OF THE WORLD INFECTION CONTROL STERILIZATION SERVICES MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 342
TABLE 152 REST OF THE WORLD INFECTION CONTROL IN-HOUSE STERILIZATION SERVICES MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 343
TABLE 153 REST OF THE WORLD INFECTION CONTROL CONTRACT STERILIZATION SERVICES MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 344
TABLE 154 REST OF THE WORLD INFECTION CONTROL MARKET REVENUE,
BY END-USERS, (2014-2022) ($MN) 345
TABLE 155 REST OF THE WORLD INFECTION CONTROL HOSPITAL ENDUSERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 346
TABLE 156 NEW PRODUCT LAUNCHES (2014-2016) 349
TABLE 157 AGREEMENTS, PARTNERSHIP, COLLABORATION & JOINT VENTURES
(2014-2016) 352
TABLE 158 APPROVALS (2014-2016) 354
TABLE 159 EXPANSIONS (2014-2016) 355
TABLE 160 MERGERS & ACQUISITIONS (2014-2016) 357
TABLE 161 3M COMPANY : TOTAL REVENUE AND R&D EXPENSES,
(2013-2015) ($MN) 363
TABLE 162 3M COMPANY : TOTAL REVENUE, BY SEGMENTS (2013-2015) ($MN) 364
TABLE 163 3M COMPANY : TOTAL REVENUE, BY GEOGRAPHY (2013-2015) ($MN) 365
TABLE 164 ANSELL LIMITED : TOTAL REVENUE AND R&D EXPENSES,
(2013-2015) ($MN) 370
TABLE 165 ANSELL LIMITED : TOTAL REVENUE, BY SEGMENTS,
(2013-2015) ($MN) 371
TABLE 166 ANSELL LIMITED : TOTAL REVENUE, BY GEOGRAPHY,
(2013-2015) ($MN) 372
TABLE 167 CANTEL MEDICAL : TOTAL REVENUE AND R&D EXPENSES,
(2013-2015) ($MN) 381
TABLE 168 CANTEL MEDICAL : TOTAL REVENUE, BY SEGMENTS
(2013-2015) ($MN) 382
TABLE 169 CANTEL MEDICAL : TOTAL REVENUE, BY GEOGRAPHY
(2013-2015) ($MN) 383
TABLE 170 GETINGE GROUPS: TOTAL REVENUE AND R&D EXPENSES,
(2013-2015) ($MN) 391
TABLE 171 GETINGE GROUPS: TOTAL REVENUE, BY SEGMENT, (2013-2015) ($MN) 392
TABLE 172 HALYARD HEALTH INC, : TOTAL REVENUE AND R&D EXPENSES,
(2013-2015) ($MN) 400
TABLE 173 HALYARD HEALTH INC, : TOTAL REVENUE, BY SEGMENTS
(2013-2015) ($MN) 401
TABLE 174 HALYARD HEALTH INC, : TOTAL REVENUE, BY GEOGRAPHY
(2013-2015) ($MN) 402
TABLE 175 HARTMANN : TOTAL REVENUE AND R&D EXPENSES,
(2013-2015) ($MN) 415
TABLE 176 HARTMANN : TOTAL REVENUE, BY SEGMENTS (2013-2015) ($MN) 416
TABLE 177 HARTMANN : TOTAL REVENUE, BY GEOGRAPHY (2013-2015) ($MN) 417
TABLE 178 JOHNSON & JOHNSON : TOTAL REVENUE AND R&D EXPENSES,
(2013-2015) ($MN) 421
TABLE 179 JOHNSON & JOHNSON : TOTAL REVENUE, BY SEGMENTS
(2013-2015) ($MN) 422
TABLE 180 JOHNSON & JOHNSON : TOTAL REVENUE, BY GEOGRAPHY
(2013-2015) ($MN) 423
TABLE 181 METALL ZUG : TOTAL REVENUE AND R&D EXPENSES,
(2013-2015) ($MN) 427
TABLE 182 METALL ZUG : TOTAL REVENUE, BY SEGMENTS (2013-2015) ($MN) 428
TABLE 183 METALL ZUG : TOTAL REVENUE, BY GEOGRAPHY (2013-2015) ($MN) 429
TABLE 184 STERIS CORPORATION : TOTAL REVENUE AND R&D EXPENSES,
(2013-2015) ($MN) 440
TABLE 185 STERIS CORPORATION : TOTAL REVENUE, BY SEGMENTS
(2013-2015) ($MN) 441
TABLE 186 STERIS CORPORATION : TOTAL REVENUE, BY GEOGRAPHY
(2013-2015) ($MN) 442
List Of Figures, Charts and Diagrams
in Infection Control Global Market - Forecast to 2022
LIST OF FIGURES
FIGURE 1 INFECTION CONTROL GLOBAL MARKET SHARE AND REVENUE,
BY REGION, (2014-2022) ($MN) 34
FIGURE 2 INFECTION CONTROL GLOBAL MARKET: RESEARCH APPROACH 45
FIGURE 3 INFECTION CONTROL GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH 46
FIGURE 4 INFECTION CONTROL GLOBAL MARKET: FORECASTING MODEL 47
FIGURE 5 INFECTION CONTROL GLOBAL MARKET: MARKET CRACKDOWN AND DATA TRIANGULATION 48
FIGURE 6 INFECTION CONTROL GLOBAL MARKET: MARKET SEGMENTATION 55
FIGURE 7 MARKET DYNAMICS 56
FIGURE 8 INFECTION CONTROL GLOBAL MARKET: PORTER’S ANALYSIS 67
FIGURE 9 INFECTION CONTROL GLOBAL MARKET: PCT PATENT FILING BY MAJOR PLAYERS (2011-2016) 77
FIGURE 10 INFECTION CONTROL GLOBAL MARKET SHARE ANALYSIS,
BY KEY PLAYERS, 2015 (%) 107
FIGURE 11 INFECTION CONTROL GLOBAL MARKET REVENUE, BY PRODUCTS, (2015 V’S 2022) ($MN) 111
FIGURE 12 INFECTION CONTROL DISINFECTION GLOBAL MARKET REVENUE,
BY TYPE, (2015 V’S 2022) ($MN) 114
FIGURE 13 INFECTION CONTROL DISINFECTORS GLOBAL MARKET REVENUE,
BY TYPE, (2015 V’S 2022) ($MN) 118
FIGURE 14 INFECTION CONTROL DISINFECTANTS GLOBAL MARKET REVENUE,
BY TYPE, (2015 V’S 2022) ($MN) 131
FIGURE 15 DISINFECTANTS GLOBAL MARKET REVENUE, BY TYPE,
(2015 V’S 2022) ($MN) 134
FIGURE 16 DISINFECTANTS EPA CLASSIFICATION GLOBAL MARKET REVENUE,
BY TYPE, (2015 V’S 2022) ($MN) 145
FIGURE 17 PERSONAL PROTECTIVE EQUIPMENTS GLOBAL MARKET REVENUE,
BY TYPE, (2015) (%) 152
FIGURE 18 INFECTION CONTROL STERILIZATION GLOBAL MARKET REVENUE,
BY TYPE, (2015 V’S 2022) ($MN) 170
FIGURE 19 INFECTION CONTROL STERILIZATION GLOBAL MARKET REVENUE,
BY METHODS, (2015 V’S 2022) ($MN) 173
FIGURE 20 INFECTION CONTROL HEAT STERILIZATION GLOBAL MARKET REVENUE, BY TYPE, (2015 V’S 2022) ($MN) 176
FIGURE 21 LOW TEMPERATURE STERILIZATION GLOBAL MARKET REVENUE,
BY TYPE, (2015) (%) 189
FIGURE 22 INFECTION CONTROL RADIATION STERILIZATION GLOBAL MARKET REVENUE, BY TYPE, (2015 V’S 2022) ($MN) 207
FIGURE 23 INFECTION CONTROL STERILIZATION GLOBAL MARKET REVENUE,
BY SERVICES, (2015 V’S 2022) ($MN) 213
FIGURE 24 INFECTION CONTROL IN-HOUSE STERILIZATION SERVICES GLOBAL MARKET REVENUE, BY TYPE, (2015 V’S 2022) ($MN) 217
FIGURE 25 INFECTION CONTROL CONTRACT STERILIZATION SERVICES GLOBAL MARKET REVENUE, BY TYPE, (2015 V’S 2022) ($MN) 228
FIGURE 26 INFECTION CONTROL GLOBAL MARKET REVENUE, BY END-USERS, (2015 V’S 2022) ($MN) 237
FIGURE 27 HOSPITALS GLOBAL MARKET REVENUE, BY TYPE,
(2015 V’S 2022) ($MN) 243
FIGURE 28 INFECTION CONTROL GLOBAL MARKET REVENUE, BY REGION,
(2014-2022) ($MN), (CAGR %) 256
FIGURE 29 NORTH AMERICAN INFECTION CONTROL MARKET REVENUE,
BY PRODUCTS AND END-USERS, (2015 V’S 2022) ($MN) 260
FIGURE 30 NORTH AMERICAN DISINFECTION AND STERILIZATION MARKET REVENUE, BY TYPE, (2015 V’S 2022) ($MN) 261
FIGURE 31 EUROPEAN INFECTION CONTROL MARKET REVENUE, BY PRODUCTS AND END-USERS, (2015 V’S 2022) ($MN) 282
FIGURE 32 EUROPEAN DISINFECTION AND STERILIZATION MARKET REVENUE,
BY TYPE, (2015 V’S 2022) ($MN) 283
FIGURE 33 ASIA-PACIFIC INFECTION CONTROL MARKET REVENUE, BY PRODUCTS AND END-USERS, (2015 V’S 2022) ($MN) 305
FIGURE 34 ASIA-PACIFIC DISINFECTION AND STERILIZATION MARKET REVENUE, BY TYPE, (2015 V’S 2022) ($MN) 306
FIGURE 35 REST OF THE WORLD INFECTION CONTROL MARKET REVENUE,
BY PRODUCTS AND END-USERS, (2015 V’S 2022) ($MN) 327
FIGURE 36 REST OF THE WORLD DISINFECTION AND STERILIZATION MARKET REVENUE, BY TYPE, (2015 V’S 2022) ($MN) 328
FIGURE 37 KEY GROWTH STRATEGIES, (2014 – 2016) 348
FIGURE 38 SWOT: 3M COMPANY 368
FIGURE 39 SWOT: ANSELL LIMITED 379
FIGURE 40 SWOT: CANTEL MEDICAL 389
FIGURE 41 SWOT: GETINGE GROUP 398
FIGURE 42 SWOT: HALYARD HEALTH INC. 413
FIGURE 43 SWOT: HARTMANN GROUP 419
FIGURE 44 SWOT: JOHNSON & JOHNSON 425
FIGURE 45 SWOT: BELIMED 432
FIGURE 46 SWOT: STERIGENICS INTERNATIONAL INC. 438
FIGURE 47 SWOT: STERIS CORPORATION 453
Additional Details
Publisher
IQ4I
Publisher Information
IQ4I is a global strategy, consulting and a leading market research company. Our clients include leading businesses, investment banks, researchers and government agencies.
We are a team of highly qualified market researchers and consultants, committed to help clients make strategic decisions by providing relevant and firmly reliable data support. We enable our clients to identify the market opportunities with best-in-class market intelligence reports and Business Development & licensing services and provide support in hiring with best talents.
Reference
111569 | Infection Control (Disinfection & Sterilization) Global Market Report 21092016
Number of Pages
454
Report Format
Related Reports
| Title | Date Published | Price from | More Details |
|---|---|---|---|
| SAVE 15% today! Diabetic Foot Infection (DFI) Global Clinical Trials Review, H2, 2018 Diabetic Foot Infection (DFI) Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical tr... | 25 Oct 2018 by Global Data | USD $2,125 (normally USD $2,500) |
More Info |
| SAVE 15% today! Infection Control (Disinfection & Sterilization) Global Market - Forecast to 2022 Healthcare associated infections which mainly includes hospital or community acquired infections are... | 21 Sep 2016 by IQ4I | USD $4,208 (normally USD $4,951) |
More Info |
| SAVE 15% today! Hazmat Suits Market by Application (Chemical Waste, Infection Control & Bio-Hazard, Hazardous Material), End-Use (Oil & Gas, Mining & Metallurgy, Construction, Manufacturing, Transportation, Utilities, Healthcare), Safety Standards - Global Forecast to 2021 “The hazmat suits market is projected to reach USD 7.97 billion by 2021”Hazmat suits are used at maj... | 13 Sep 2016 by MarketsandMarkets | USD $4,803 (normally USD $5,651) |
More Info |
| SAVE 15% today! Infection Surveillance Solutions Market by Product (Software (On Premise, Web Based), Services (Training & Consulting, Implementation)), End User (Hospitals, LTCs, Nursing Home, Skilled Nursing Facility, Assisted Living) - Global Forecast to 2021 “Infection Surveillance Solutions Market, By Product [Software (On Premise, Web Based), Services (Tr... | 14 Jun 2016 by MarketsandMarkets | USD $4,803 (normally USD $5,651) |
More Info |
| SAVE 15% today! Diabetic Foot Infection (DFI) Global Clinical Trials Review, H1, 2016 Diabetic Foot Infection (DFI) Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical tr... | 31 May 2016 by Global Data | USD $2,125 (normally USD $2,500) |
More Info |
| SAVE 15% today! Diabetic Foot Infection (DFI) Global Clinical Trials Review, H1, 2016 Diabetic Foot Infection (DFI) Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical tr... | 31 May 2016 by Global Data | USD $2,125 (normally USD $2,500) |
More Info |
| SAVE 15% today! H5N1 Infection (Avian Influenza) Global Clinical Trials Review, H1, 2016 H5N1 Infection (Avian Influenza) Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical... | 20 Jan 2016 by Global Data | USD $2,125 (normally USD $2,500) |
More Info |
| SAVE 15% today! EpiCast Report: Respiratory Syncytial Virus Infection - Epidemiology Forecast to 2024 EpiCast Report: Respiratory Syncytial Virus Infection - Epidemiology Forecast to 2024SummaryRSV is a... | 23 Dec 2015 by Global Data | USD $3,396 (normally USD $3,995) |
More Info |
| SAVE 15% today! Viral Respiratory Tract Infection Global Clinical Trials Review, H2, 2015 Viral Respiratory Tract Infection Global Clinical Trials Review, H2, 2015SummaryGlobalData's clinica... | 25 Nov 2015 by Global Data | USD $2,125 (normally USD $2,500) |
More Info |
| SAVE 15% today! Rhinovirus Infection Global Clinical Trials Review, H2, 2015 Rhinovirus Infection Global Clinical Trials Review, H2, 2015SummaryGlobalData's clinical trial repor... | 25 Nov 2015 by Global Data | USD $2,125 (normally USD $2,500) |
More Info |
This report is published by IQ4I
IQ4I is a global strategy, consulting and a leading market research company. Our clients include leading businesses, investment banks, researchers and government agencies.
We are a team of highly qualified market researchers and consultants, committed to help clients make strategic decisions by providing relevant and firmly reliable data support. We enable our clients to identify the market opportunities with best-in-class market intelligence reports and Business Development & licensing services and provide support in hiring with best talents.
Download Free Report Summary PDF
Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.
Ordering Information
Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.
Accepted Card Types
Buy now using our secure payment system.